SORIATANE

LOE Approaching

acitretin

NDAORALCAPSULE
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
5

Clinical Trials (5)

NCT01228409Phase 4Unknown

Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

Started Oct 2010
20 enrolled
Psoriasis
NCT00936065Phase 4Completed

Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

Started Jul 2009
60 enrolled
Moderate to Severe Psoriasis
NCT00707070Phase 4Unknown

Combining Acitretin and Efalizumab in the Therapy of Chronic Plaque Psoriasis

Started Sep 2008
100 enrolled
Chronic Plaque Psoriasis
NCT00003611N/ACompleted

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

Started May 2000
129 enrolled
Non-melanomatous Skin Cancer
NCT00002143Phase 3Completed

Treatment of Psoriasis Using Acitretin in HIV-Positive Patients

30 enrolled
HIV InfectionsPsoriasis
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.